Dexmedetomidine Use in a Tertiary Care NICU: A Descriptive Study
- 3 December 2018
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 53 (5) , 464-470
Abstract
Background: Continuous infusions of dexmedetomidine are increasingly used for sedation in critically ill pediatric patients. Emerging data suggest potential benefits when used for sedation in neonates, including reduced sedative requirements and earlier enteral feeds. Objective: To describe the use, adverse effects, and signs of withdrawal in a cohort of neonates receiving dexmedetomidine, the majority of whom were receiving concomitant opioids. Methods: This was a retrospective, descriptive review of 38 neonates receiving dexmedetomidine in a medical surgical neonatal intensive care unit, including data on duration of use, dose, adverse effects, weaning, and signs of withdrawal. Results: Dexmedetomidine was used for a median of 183 hours, at a median maximum dose of 0.5 µg/kg/h. Premature infants were started on dexmedetomidine at a later chronological age than term infants (41 vs 9 days, P = 0.004). Of 18 patients receiving an opioid infusion at the time of dexmedetomidine initiation, 67% had a dose reduction in opioids by 24 hours. The majority (89%) of neonates had at least 1 potentially related adverse effect during the dexmedetomidine infusion, though no discontinuations were needed as a result. In all, 80% of patients had their dexmedetomidine gradually weaned off, and 71% had at least 1 sign of withdrawal. Conclusions and Relevance: In this cohort, dexmedetomidine was often used in a postsurgical setting, with concomitant opioids, over prolonged periods. These factors appear to affect and likely confound the rates of adverse effects and withdrawal signs from dexmedetomidine. Clinicians considering the use of dexmedetomidine in a similar population can draw guidance from our data.Keywords
This publication has 26 references indexed in Scilit:
- Opioid Analgesia in Mechanically Ventilated ChildrenPediatric Critical Care Medicine, 2013
- Dexmedetomidine Versus Standard Therapy with Fentanyl for Sedation in Mechanically Ventilated Premature NeonatesThe Journal of Pediatric Pharmacology and Therapeutics, 2012
- Sedation and Analgesia in Mechanically Ventilated Preterm Neonates: Continue Standard of Care or Experiment?The Journal of Pediatric Pharmacology and Therapeutics, 2012
- Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart diseaseIntensive Care Medicine, 2011
- Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patientsAmerican Journal of Health-System Pharmacy, 2011
- Hypertension in infancy: diagnosis, management and outcomePediatric Nephrology, 2011
- Part 14: Pediatric Advanced Life SupportCirculation, 2010
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPediatrics, 2010
- Clonidine as an Adjunct Therapy to Opioids for Neonatal Abstinence Syndrome: A Randomized, Controlled TrialPediatrics, 2009
- α2-Adrenoceptor agonists: shedding light on neuroprotection?British Medical Bulletin, 2005